IBDEI1GT ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23431,1,3,0)
 ;;=3^Hepatitis w/o Hepatic Coma,Unspec
 ;;^UTILITY(U,$J,358.3,23431,1,4,0)
 ;;=4^B19.9
 ;;^UTILITY(U,$J,358.3,23431,2)
 ;;=^5000554
 ;;^UTILITY(U,$J,358.3,23432,0)
 ;;=K75.89^^105^1174^44
 ;;^UTILITY(U,$J,358.3,23432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23432,1,3,0)
 ;;=3^Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,23432,1,4,0)
 ;;=4^K75.89
 ;;^UTILITY(U,$J,358.3,23432,2)
 ;;=^5008829
 ;;^UTILITY(U,$J,358.3,23433,0)
 ;;=B00.1^^105^1174^46
 ;;^UTILITY(U,$J,358.3,23433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23433,1,3,0)
 ;;=3^Herpesviral Vesicular Dermatitis
 ;;^UTILITY(U,$J,358.3,23433,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,23433,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,23434,0)
 ;;=A60.01^^105^1174^47
 ;;^UTILITY(U,$J,358.3,23434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23434,1,3,0)
 ;;=3^Herpetic Infect of Penis
 ;;^UTILITY(U,$J,358.3,23434,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,23434,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,23435,0)
 ;;=A60.04^^105^1174^48
 ;;^UTILITY(U,$J,358.3,23435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23435,1,3,0)
 ;;=3^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,23435,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,23435,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,23436,0)
 ;;=Z21.^^105^1174^36
 ;;^UTILITY(U,$J,358.3,23436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23436,1,3,0)
 ;;=3^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,23436,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,23436,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,23437,0)
 ;;=B20.^^105^1174^35
 ;;^UTILITY(U,$J,358.3,23437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23437,1,3,0)
 ;;=3^HIV + (Symptomatic)/AIDS
 ;;^UTILITY(U,$J,358.3,23437,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,23437,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,23438,0)
 ;;=A63.0^^105^1174^50
 ;;^UTILITY(U,$J,358.3,23438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23438,1,3,0)
 ;;=3^Human Papillomavirus infection
 ;;^UTILITY(U,$J,358.3,23438,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,23438,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,23439,0)
 ;;=T85.79XA^^105^1174^67
 ;;^UTILITY(U,$J,358.3,23439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23439,1,3,0)
 ;;=3^Infect/inflm reaction d/t implantable device graft,init encntr
 ;;^UTILITY(U,$J,358.3,23439,1,4,0)
 ;;=4^T85.79XA
 ;;^UTILITY(U,$J,358.3,23439,2)
 ;;=^5055676
 ;;^UTILITY(U,$J,358.3,23440,0)
 ;;=J11.00^^105^1174^79
 ;;^UTILITY(U,$J,358.3,23440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23440,1,3,0)
 ;;=3^Influenza with unspecified type of pneumonia
 ;;^UTILITY(U,$J,358.3,23440,1,4,0)
 ;;=4^J11.00
 ;;^UTILITY(U,$J,358.3,23440,2)
 ;;=^5008156
 ;;^UTILITY(U,$J,358.3,23441,0)
 ;;=H83.09^^105^1174^80
 ;;^UTILITY(U,$J,358.3,23441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23441,1,3,0)
 ;;=3^Labyrinthitis, NOS
 ;;^UTILITY(U,$J,358.3,23441,1,4,0)
 ;;=4^H83.09
 ;;^UTILITY(U,$J,358.3,23441,2)
 ;;=^5006897
 ;;^UTILITY(U,$J,358.3,23442,0)
 ;;=H83.02^^105^1174^82
 ;;^UTILITY(U,$J,358.3,23442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23442,1,3,0)
 ;;=3^Labyrinthitis, left ear
 ;;^UTILITY(U,$J,358.3,23442,1,4,0)
 ;;=4^H83.02
 ;;^UTILITY(U,$J,358.3,23442,2)
 ;;=^5006895
 ;;^UTILITY(U,$J,358.3,23443,0)
 ;;=H83.01^^105^1174^83
 ;;^UTILITY(U,$J,358.3,23443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23443,1,3,0)
 ;;=3^Labyrinthitis, right ear
